Corresponding Author: Alex H. Krist, MD, MPH, Virginia Commonwealth University, 830 East Main St, One Capitol Square, Sixth Floor, Richmond, VA 23219 (firstname.lastname@example.org).
Accepted for Publication: September 25, 2020.
The US Preventive Services Task Force (USPSTF) members: Alex H. Krist, MD, MPH; Karina W. Davidson, PhD, MASc; Carol M. Mangione, MD, MSPH; Michael J. Barry, MD; Michael Cabana, MD, MA, MPH; Aaron B. Caughey, MD, PhD; Katrina Donahue, MD, MPH; Chyke A. Doubeni, MD, MPH; John W. Epling Jr, MD, MSEd; Martha Kubik, PhD, RN; Gbenga Ogedegbe, MD, MPH; Lori Pbert, PhD; Michael Silverstein, MD, MPH; Melissa A. Simon, MD, MPH; Chien-Wen Tseng, MD, MPH, MSEE; John B. Wong, MD.
Affiliations of The US Preventive Services Task Force (USPSTF) members: Fairfax Family Practice Residency, Fairfax, Virginia (Krist); Virginia Commonwealth University, Richmond (Krist); Feinstein Institute for Medical Research at Northwell Health, Manhasset, New York (Davidson); University of California, Los Angeles (Mangione); Harvard Medical School, Boston, Massachusetts (Barry); University of California, San Francisco (Cabana); Oregon Health & Science University, Portland (Caughey); University of North Carolina at Chapel Hill (Donahue); Mayo Clinic, Rochester, Minnesota (Doubeni); Virginia Tech Carilion School of Medicine, Roanoke (Epling Jr); George Mason University, Fairfax, Virginia (Kubik); New York University, New York, New York (Ogedegbe); University of Massachusetts Medical School, Worcester (Pbert); Boston University, Boston, Massachusetts (Silverstein); Northwestern University, Evanston, Illinois (Simon); University of Hawaii, Honolulu (Tseng); Pacific Health Research and Education Institute, Honolulu, Hawaii (Tseng); Tufts University School of Medicine, Boston, Massachusetts (Wong).
Author Contributions: Dr Krist had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The USPSTF members contributed equally to the recommendation statement.
Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described at https://www.uspreventiveservicestaskforce.org/Page/Name/conflict-of-interest-disclosures. All members of the USPSTF receive travel reimbursement and an honorarium for participating in USPSTF meetings. Dr Barry reported receiving grants and personal fees from Healthwise.
Funding/Support: The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.
Role of the Funder/Sponsor: AHRQ staff assisted in the following: development and review of the research plan, commission of the systematic evidence review from an Evidence-based Practice Center, coordination of expert review and public comment of the draft evidence report and draft recommendation statement, and the writing and preparation of the final recommendation statement and its submission for publication. AHRQ staff had no role in the approval of the final recommendation statement or the decision to submit for publication.
Disclaimer: Recommendations made by the USPSTF are independent of the US government. They should not be construed as an official position of AHRQ or the US Department of Health and Human Services.
Additional Contributions: We thank Iris Mabry-Hernandez, MD, MPH (AHRQ), who contributed to the writing of the manuscript, and Lisa Nicolella, MA (AHRQ), who assisted with coordination and editing.
Additional Information: The US Preventive Services Task Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients without obvious related signs or symptoms. It bases its recommendations on the evidence of both the benefits and harms of the service and an assessment of the balance. The USPSTF does not consider the costs of providing a service in this assessment. The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision making to the specific patient or situation. Similarly, the USPSTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms.
G , Vander Schaaf
EB , Orr
C , Kennedy
SM , Clark
R , Viswanathan
M . Screening for Hypertension in Children and Adolescents: Systematic Review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 193. Agency for Healthcare Research and Quality; 2020. AHRQ publication 20-05261-EF-1.
KL , Poffenbarger
TS , Turner
et al. Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr
. 2007;150(6):640-644.Google ScholarCrossref
JT , Pierce
CB , Miller
et al; Chronic Kidney Disease in Children Study Group. Reliability of resting blood pressure measurement and classification using an oscillometric device in children with chronic kidney disease. J Pediatr
. 2012;160(3):434-440. doi:10.1016/j.jpeds.2011.08.071PubMedGoogle ScholarCrossref
JT , Kaelber
DC , Baker-Smith
et al; Subcommittee on Screening and Management of High Blood Pressure in Children. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics
. 2017;140(3):e20171904. doi:10.1542/peds.2017-1904PubMedGoogle Scholar
PK , Carey
RM , Aronow
et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation
. 2018;138(17):e426-e483.PubMedGoogle Scholar
DC , Bibbins-Domingo
K , Curry
et al; US Preventive Services Task Force. Screening for obesity in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA
. 2017;317(23):2417-2426. doi:10.1001/jama.2017.6803PubMedGoogle ScholarCrossref
K , Grossman
DC , Curry
et al; US Preventive Services Task Force. Screening for lipid disorders in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA
. 2016;316(6):625-633. doi:10.1001/jama.2016.9852PubMedGoogle ScholarCrossref
VA ; US Preventive Services Task Force. Screening for primary hypertension in children and adolescents: U.S. Preventive Services Task Force recommendation statement. Pediatrics
. 2013;132(5):907-914. doi:10.1542/peds.2013-2864PubMedGoogle ScholarCrossref
G , Vander Schaaf
EB , Orr
C , Kennedy
SM , Clark
R , Viswanathan
M . Screening for hypertension in children and adolescents: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA
. Published November 10, 2020. doi:10.1001/jama.2020.11119Google Scholar
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics
. 2004;114(2 suppl 4th report):555-576. PubMedCrossref
WM , Sung
KD , Bharath
LP , Choi
KJ , Park
SY . Combined exercise training reduces blood pressure, arterial stiffness, and insulin resistance in obese prehypertensive adolescent girls. Clin Exp Hypertens
. 2017;39(6):546-552. doi:10.1080/10641963.2017.1288742PubMedGoogle ScholarCrossref
HS , Froberg
K , Hyldebrandt
N , Nielsen
JR . A controlled study of eight months of physical training and reduction of blood pressure in children: the Odense Schoolchild Study. BMJ
. 1991;303(6804):682-685. doi:10.1136/bmj.303.6804.682PubMedGoogle ScholarCrossref
SC , Saelens
BE , Levin
L , Dart
K , Falciglia
G , Daniels
SR . The efficacy of a clinic-based behavioral nutrition intervention emphasizing a DASH-type diet for adolescents with elevated blood pressure. J Pediatr
. 2008;152(4):494-501. doi:10.1016/j.jpeds.2007.09.022PubMedGoogle ScholarCrossref
JT , Daniels
SR , Hayman
et al; American Heart Association Atherosclerosis, Hypertension and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young. Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertension
. 2014;63(5):1116-1135. doi:10.1161/HYP.0000000000000007PubMedGoogle ScholarCrossref
Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics
. 2011;128(suppl 5):S213-S256. doi:10.1542/peds.2009-2107CPubMedGoogle ScholarCrossref